• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Procollagen galactosyltransferase 2 (GLT25D2)

ACP14934

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP14934 Target NameCOLGALT2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range28-626Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8IYK4
Background Information
  • Uniprot Id

    Q8IYK4

  • Target Species

    Human

  • Target Name

    COLGALT2

  • Target Full Name

    Procollagen galactosyltransferase 2

  • Target Function

    Beta-galactosyltransferase that transfers beta-galactose to hydroxylysine residues of collagen.

  • Target Subcellular Location

    Endoplasmic reticulum lumen.

  • Target Protein Families

    Glycosyltransferase 25 family

  • Target Tissue Specificity

    Expressed in brain and skeletal muscle.

  • Target Synonyms

    C1orf17; COLGALT2; Collagen beta(1 O)galactosyltransferase 2; Glt25d2; Glycosyltransferase 25 domain containing 2; Glycosyltransferase 25 family member 2; GT252_HUMAN; Hydroxylysine galactosyltransferase 2; Procollagen galactosyltransferase 2; RP11-498P10.2

  • Target Background

    Predicted to enable procollagen galactosyltransferase activity. Predicted to be involved in collagen fibril organization. Predicted to be located in endoplasmic reticulum lumen.

Inquire Recombinant Human Procollagen galactosyltransferase 2 (GLT25D2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification